LYNN BLAKESLEE: Open Payments
NPI 1356348353 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 33 payments from 12 companies in 2025. Trend: 2023 $740 · 2024 $873 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $121 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| United Therapeutics Corporation | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| PFIZER INC. | 3 | $62 |
| Boston Scientific Corporation | 1 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Chiesi USA, Inc. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
Products named: LEQVIO, VERQUVO, VYNDAQEL, Tyvaso, LOKELMA, WATCHMAN FLX, FUROSCIX, ONPATTRO.
Industry payments across OH — which companies pay providers there.
